United States · FDA National Drug Code directory
Optison Perflutren Protein-Type A Microspheres
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0407-2707_37a56077-bf10-4afa-b405-7f80967f41e6
- Product NDC
- 0407-2707
- Form
- INJECTION, SOLUTION
- Composition / generic term
- Human Albumin Microspheres and Perflutren
- Labeler
- GE Healthcare Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20020102
- Source listing expiry
- 20261231
Source-listed ingredients
- HUMAN ALBUMIN MICROSPHERES — 10 mg/mL
- PERFLUTREN — .22 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 5 VIAL, SINGLE-USE in 1 CARTON (0407-2707-03) / 3 mL in 1 VIAL, SINGLE-USE · 0407-2707-03
- 18 VIAL, SINGLE-USE in 1 CARTON (0407-2707-18) / 3 mL in 1 VIAL, SINGLE-USE · 0407-2707-18
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →